Pharma Mar SA banner

Pharma Mar SA
F:PMRA

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
F:PMRA
Watchlist
Price: 72.85 EUR 0.55% Market Closed
Market Cap: €1.3B

Wall St Price Targets

PMRA Price Forecast
Based on 12 analysts

+51% Upside
from €72.85 today

Pharma Mar SA (PMRA)’s 12-month stock price forecast through October 2027 has a consensus target of €110.29, implying 51% upside. The forecast is based on price targets from 12 Wall Street analysts.

PMRA Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for PMRA yet.

Pharma Mar SA Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PMRA's stock price target?
Price Target
110.29 EUR

According to Wall Street analysts, the average 1-year price target for PMRA is 110.29 EUR with a low forecast of 68.43 EUR and a high forecast of 141.92 EUR.

What is the Revenue forecast for Pharma Mar SA?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for Pharma Mar SA?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 17%.

What is the Operating Income forecast for Pharma Mar SA?
Projected CAGR
27%

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 27%.

What is the Pre-Tax Income forecast for Pharma Mar SA?
Projected CAGR
46%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 46%.

What is the Net Income forecast for Pharma Mar SA?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 8 years is 19%.

Back to Top